Biotech · Private company
ViaCyte
Track this companyFree. Adds ViaCyte to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- VC-01 Combination ProductPhase 2 · Type 1 DiabetesClinicalTrials.gov · fetched Nov 12, 2026
- VC-01™ Combination ProductPhase 2 · Type 1 Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- VC-02 Combination ProductPhase 2 · Type 1 Diabetes Mellitus With HypoglycemiaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study to Evaluate Safety, Engraftment, and Efficacy of VC-01 in Subjects With T1 Diabetes MellitusPHASE1_PHASE2 · TERMINATED · started Jun 25, 2019ClinicalTrials.gov NCT04678557 · fetched Nov 12, 2026
- A Safety, Tolerability, and Efficacy Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia UnawarenessPHASE1_PHASE2 · COMPLETED · started Jul 6, 2017ClinicalTrials.gov NCT03163511 · fetched Nov 12, 2026
- A Safety, Tolerability, and Efficacy Study of VC-01™ Combination Product in Subjects With Type I Diabetes MellitusPHASE1_PHASE2 · TERMINATED · started Sep 1, 2014ClinicalTrials.gov NCT02239354 · fetched Nov 12, 2026